Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea

<p> Yu.Yu. Chebotareva, Yu.A. Petrov </p> <p> Rostov State Medical University, Rostov-on-Don, Russian Federation </p> <p> Dysmenorrhea is a complex of symptoms that most commonly occurs a day before or on the first day of menstruation. This paper describes in deta...

Full description

Bibliographic Details
Main Authors: Yu.Yu. Chebotareva, Yu.A. Petrov
Format: Article
Language:Russian
Published: LCC «Medicine-Inform» 2022-05-01
Series:РМЖ. Мать и дитя
Online Access:http://wchjournal.com/upload/iblock/cd5/cd54ee68ff09b736db5225f30618b9ab.pdf
_version_ 1827341315704094720
author Yu.Yu. Chebotareva
Yu.A. Petrov
author_facet Yu.Yu. Chebotareva
Yu.A. Petrov
author_sort Yu.Yu. Chebotareva
collection DOAJ
description <p> Yu.Yu. Chebotareva, Yu.A. Petrov </p> <p> Rostov State Medical University, Rostov-on-Don, Russian Federation </p> <p> Dysmenorrhea is a complex of symptoms that most commonly occurs a day before or on the first day of menstruation. This paper describes in detail risk factors and prevalence of the primary and secondary dysmenorrhea. The authors discuss the etiology and pathogenesis of period pain, the mechanism of analgesic action of&nbsp; combined analgesic, and its use for primary dysmenorrhea depending on its severity. Systematic reviews of the comparative analysis of the efficacy of management strategies for primary dysmenorrhea have demonstrated that NSAIDs are beneficial for moderate-to-severe pelvic pain. A broad effect of NSAIDs on pain relief is mediated by reducing the production of prostaglandins (inflammatory mediators). NSAIDs or antispasmodics are most commonly used to reduce dysmenorrhea symptoms. Russian scientists focus on fixed-dose combinations of NSAIDs and myotropic antispasmodics, e.g., ibuprofen, pitofenone hydrochloride (myotropic antispasmodic), and fenpiverinium bromide (M-cholinoblocker with central and peripheral action). The pathogenic basis for the use of this combination for primary dysmenorrhea is addressed. </p> <p> <b>Keywords: </b>primary dysmenorrhea, pelvic pain, NSAIDs, menstrual pain, myotropic antispasmodic, M-cholinoblocker, fixed-dose combination. </p> <p> <b>For citation:</b> Chebotareva Yu.Yu., Petrov Yu.A. Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea. Russian Journal of Woman and Child Health. 2022;5(2)146:–152 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-146-152. </p>
first_indexed 2024-03-07T21:38:15Z
format Article
id doaj.art-1fcfbfb515e04d86ae253576e49f7664
institution Directory Open Access Journal
issn 2618-8430
2686-7184
language Russian
last_indexed 2024-03-07T21:38:15Z
publishDate 2022-05-01
publisher LCC «Medicine-Inform»
record_format Article
series РМЖ. Мать и дитя
spelling doaj.art-1fcfbfb515e04d86ae253576e49f76642024-02-26T10:13:33ZrusLCC «Medicine-Inform»РМЖ. Мать и дитя2618-84302686-71842022-05-015233578Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrheaYu.Yu. Chebotareva0Yu.A. Petrov1Russian Journal of Woman and Child Health, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Woman and Child Health, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> Yu.Yu. Chebotareva, Yu.A. Petrov </p> <p> Rostov State Medical University, Rostov-on-Don, Russian Federation </p> <p> Dysmenorrhea is a complex of symptoms that most commonly occurs a day before or on the first day of menstruation. This paper describes in detail risk factors and prevalence of the primary and secondary dysmenorrhea. The authors discuss the etiology and pathogenesis of period pain, the mechanism of analgesic action of&nbsp; combined analgesic, and its use for primary dysmenorrhea depending on its severity. Systematic reviews of the comparative analysis of the efficacy of management strategies for primary dysmenorrhea have demonstrated that NSAIDs are beneficial for moderate-to-severe pelvic pain. A broad effect of NSAIDs on pain relief is mediated by reducing the production of prostaglandins (inflammatory mediators). NSAIDs or antispasmodics are most commonly used to reduce dysmenorrhea symptoms. Russian scientists focus on fixed-dose combinations of NSAIDs and myotropic antispasmodics, e.g., ibuprofen, pitofenone hydrochloride (myotropic antispasmodic), and fenpiverinium bromide (M-cholinoblocker with central and peripheral action). The pathogenic basis for the use of this combination for primary dysmenorrhea is addressed. </p> <p> <b>Keywords: </b>primary dysmenorrhea, pelvic pain, NSAIDs, menstrual pain, myotropic antispasmodic, M-cholinoblocker, fixed-dose combination. </p> <p> <b>For citation:</b> Chebotareva Yu.Yu., Petrov Yu.A. Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea. Russian Journal of Woman and Child Health. 2022;5(2)146:–152 (in Russ.). DOI: 10.32364/2618-8430-2022-5-2-146-152. </p>http://wchjournal.com/upload/iblock/cd5/cd54ee68ff09b736db5225f30618b9ab.pdf
spellingShingle Yu.Yu. Chebotareva
Yu.A. Petrov
Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
РМЖ. Мать и дитя
title Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
title_full Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
title_fullStr Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
title_full_unstemmed Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
title_short Pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
title_sort pathogenic basis for the use of a combined analgesic for pain relief in primary dysmenorrhea
url http://wchjournal.com/upload/iblock/cd5/cd54ee68ff09b736db5225f30618b9ab.pdf
work_keys_str_mv AT yuyuchebotareva pathogenicbasisfortheuseofacombinedanalgesicforpainreliefinprimarydysmenorrhea
AT yuapetrov pathogenicbasisfortheuseofacombinedanalgesicforpainreliefinprimarydysmenorrhea